TABLE 2.
Variable | N | Cut-pointc | Sensitivitye | Specificitye | Accuracye | AUCb | P valuea |
---|---|---|---|---|---|---|---|
Siderophore | 49 | >100f | .82 (13/16) | 0.33 (11/33) | 0.49 (24/49) | 0.502 | 0.860 |
Mucoviscosity LB | 49 | >0.11 | .63 (10/16) | 0.76 (25/33) | 0.71 (35/49) | 0.723 | 0.034 |
Mucoviscosity c-M9-CA-te | 49 | >0.088 | 1.0 (16/16) | 0.70 (23/33) | 0.80 (39/49) | 0.869 | 0.001 |
Marker count | 49 | 5 | 0.94 (15/16) | 0.94 (31/33) | 0.94 (46/49) | 0.962 | 0.004 |
Marker count | 49 | ≥4d | 1 (16/16) | 0.76 (25/33) | 0.84 (41/49) | ||
Kleborate score | 49 | >4.05 | 0.44 (7/16) | 0.94 (31/33) | 0.78 (38/49) | 0.768 | 0.003 |
Mash | 29 | <0.008 | 0.77 (7/9) | 0.9 (18/20) | 0.86 (25/29) | 0.900 | <0.001 |
Jaccard | 29 | <0.318 | 0.77 (7/9) | 0.95 (19/20) | 0.90 (26/29) | 0.919 | <0.001 |
Exact test about the odds ratio from logistic regression model.
Area under the ROC curve.
Derived from classification and regression tree (CART) prediction model.
Assessment at a potentially clinically relevant cut-point.
Computed using cut-point values.
Determined from ROC curve.